Cargando…
The efficacy and safety of DW1601 in patients with acute bronchitis: a multi-center, randomized, double-blind, phase III clinical trial
BACKGROUND/AIMS: DW1601, an oral fixed dose combination syrup composed of DW16011 and Pelargonium sidoides, was developed to enhance the symptom relief effect in patients with acute bronchitis. We evaluated the efficacy and safety of DW1601 compared to DW16011 or P. sidoides for treatment of acute b...
Autores principales: | Lee, Young Seok, Lim, Seong Yong, Min, Kyung Hoon, Kim, Do Jin, Yoo, Kwang Ha, Kim, Tae-Bum, Kim, Hak-Ryul, Shim, Jae Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666245/ https://www.ncbi.nlm.nih.gov/pubmed/36153858 http://dx.doi.org/10.3904/kjim.2022.104 |
Ejemplares similares
-
Anti-Inflammatory Effects of Limosilactobacillus fermentum KGC1601 Isolated from Panax ginseng and Its Probiotic Characteristics
por: Kim, Heejin, et al.
Publicado: (2022) -
The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial
por: Ra, Seung Won, et al.
Publicado: (2021) -
Effects of a Mixture of Ivy Leaf Extract and Coptidis rhizome on Patients with Chronic Bronchitis and Bronchiectasis
por: Hong, Goohyeon, et al.
Publicado: (2021) -
Poor relief in England and Wales 1601–1834
Publicado: (1976) -
Different Pattern of Chronic Obstructive Pulmonary Disease Assessment Test Score between Chronic Bronchitis and Non-chronic Bronchitis Patients
por: Yoo, Sang Hoon, et al.
Publicado: (2018)